Multiplex Assays: Technologies, Applications And Markets

Table of Contents

• Chapter 1. Introduction: Evolution of Assay Technologies in the Pharmaceutical and Diagnostic Industries
  • 1.1. Brief History of Biomedical Assays
  • 1.2. Rise of the Multiplex Assay Concept
• Chapter 2. Current State of Multiplex Assay Technologies
  • 2.1. Microarrays
  • Positional Microarrays
  • Encoded Particle Arrays
  • Amplification-Based Technologies
  • Mass Spectrometric and Other Multiplex Assay Technologies
  • 2.2. Comparative SWOT Analysis of Technologies
• Chapter 3. Multiplex Assay Products and Applications
  • 3.1. Drug Discovery and Development
  • Drug Discovery
  • Drug Development
  • Relevant Products
  • Drivers and Barriers to Adoption
  • 3.2. Diagnostics
  • Classic Diagnostic Panels
  • Point-of-Care Diagnostics
  • Cancer Diagnostics
  • Drivers and Barriers to Adoption
• Chapter 4. Future Directions for Multiplex Technologies
  • 4.1. Areas That Need Improvement
  • Real-Time Polymerase Chain Reaction
  • Antibody Microarrays
  • SELDI-TOF
  • 4.2. Trends and Prospects for Improvement
  • Real-Time Polymerase Chain Reaction
  • Antibody Microarrays
  • SELDI-TOF
  • 4.3. Conclusion
• Chapter 5. The Multiplex Assay Market
  • 5.1. Market Analysis
  • Research
  • -Market Drivers for Multiplex Research Assays
  • -Barriers to Market Expansion for Multiplex Research Assays
  • Diagnostics
  • -Drivers for the Diagnostic Segment of the Multiplex Assay Market
  • -Barriers for the Diagnostic Segment of the Multiplex Assay Market
  • 5.2. Revenue Estimates and Projections
  • 5.3. Deals
  • 5.4. Conclusions
• Chapter 6. Selected Company Profiles
  • 6.1. Extended Selected Company Profiles
  • -Biosite
  • -Ciphergen
  • -Epigenomics AG
  • -Luminex Corporation
  • -Nanogen
  • 6.2. Selected Company Profiles
  • -Agendia
  • -Biacore
  • -BioArray Solutions
  • -Correlogic Systems
  • -Epitome Biosystems
  • -EraGen Biosciences
  • -Genomic Health
  • -Gyros
  • -High Throughput Genomics
  • -Invitrogen (Molecular Probes Unit)
  • -MetriGenix
  • -Monogram Biosciences
  • -OncoMethylome Sciences
  • -Power3 Medical Products
  • -Predicant Biosciences
  • -Randox Laboratories Ltd.
  • -Tm Bioscience
• Chapter 7. Expert Interviews
  • William Coty, Osmetech
  • Brian Edmonds, Eli Lilly
  • Dr. Neal F. Gordon, Epitome Biosystems, Inc.
  • James W. Jacobson, PhD, Luminex
  • Yuling Luo, PhD, Genospectra (now Panomics)
  • Dr. James Prudent, EraGen Biosciences
  • Bruce Seligmann, High Throughput Genomics
  • Gunars Valkirs, Biosite Discovery
• References
• Glossary
• Company Index with Web Sites